CD4 and glaucoma: In our current study, we utilized clinical samples, an EIOP-induced glaucoma mouse model with antibody-mediated treatments, and T cell transfer models, revealing the following findings: (i) circulating CD4+ T cells from glaucoma patients exhibited significantly upregulated activation and developed Th1-biased responses.